...
机译:吉西他滨和长春瑞滨(GV)与顺铂,吉西他滨和长春瑞滨(CGV)作为晚期非小细胞肺癌的一线治疗:一项前瞻性随机II期研究的结果
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo)Clinical Oncology Services of the Hospital Central de Asturias;
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital de León;
Clinical Oncology Services of the Hospital de Ponferrada;
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Clinical Oncology Services of the Hospital Central de Asturias (Oviedo);
Gemcitabine; vinorelbine; cisplatin; NSCLC;
机译:吉西他滨和长春瑞滨(GV)与顺铂,吉西他滨和长春瑞滨(CGV)作为晚期非小细胞肺癌的一线治疗:一项前瞻性随机II期研究的结果。
机译:吉西他滨和长春瑞滨与吉西他滨,长春瑞滨和顺铂治疗晚期非小细胞肺癌的随机III期研究:来自德国和瑞士肺癌研究组。
机译:比较顺铂,吉西他滨和长春瑞滨与顺铂和吉西他滨或顺铂和长春瑞滨在晚期非小细胞肺癌中的随机对照试验:意大利南部合作公司Onco的III期临床试验的中期分析
机译:Gemcitabine +顺铂组合电化学疗法三重阴性乳腺癌:体外模型研究
机译:吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
机译:长春瑞滨和吉西他滨与长春瑞滨和卡铂作为晚期NSCLC的一线治疗。挪威肺癌研究小组进行的III期随机对照试验
机译:P2-311:卡铂和紫杉醇(CP)对比吉西他滨和长春瑞滨(GV)的运动状态(PS)2晚期非小细胞肺癌(NSCLC)患者的II期随机研究:西日本胸腔肿瘤小组的结果研究(WJTOG0004)